Our portfolio

Portfolio
Overview: PDF Excel Click here to open search box

Search in site

IP Group holding: 23.4%*

Developing a high performance decoding solution for 5G mobile communication

DeepTech

IP Group holding: 39.2%*

3D printing quality monitoring

DeepTech

IP Group holding: 6.7%*

Clinical stage oncology company based on a tumor-specific immuno-gene therapy platform

HealthTech

IP Group holding: 37.7%*

Medical devices to improve the safety, efficiency and outcomes of advanced surgical procedures

HealthTech

IP Group holding: 21.5%*

Next-generation technology for gastric disorders

HealthTech

IP Group holding: 6.5%*

Carbon capture and mineralization technology to reuse industrial wastes from the concrete industry

CleanTech

IP Group holding: 34.0%*

Long-range and efficient eVTOL

CleanTech

IP Group holding: 1.1%*

Biopharmaceutical company translating breakthroughs in biology and basic medical research into innovative new medicines

HealthTech

IP Group holding: 23.9%*

Unique solutions for encapsulation based on cutting-edge research

DeepTech

IP Group holding: 6.8%*

Novel oncology therapies that leverage the changes in the DNA Damage Response (DDR) in cancer cells

HealthTech

IP Group holding: 38.4%*

Personalised, trackable 3D sound projection technology

DeepTech

IP Group holding: 30.7%*

Novel heat exchanger technology

CleanTech

*Holding percentages in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

Showing XX of 57

IP Group holding: 23.4%*

Developing a high performance decoding solution for 5G mobile communication

DeepTech

IP Group holding: 39.2%*

3D printing quality monitoring

DeepTech

IP Group holding: 6.7%*

Clinical stage oncology company based on a tumor-specific immuno-gene therapy platform

HealthTech

IP Group holding: 37.7%*

Medical devices to improve the safety, efficiency and outcomes of advanced surgical procedures

HealthTech

IP Group holding: 21.5%*

Next-generation technology for gastric disorders

HealthTech

IP Group holding: 6.5%*

Carbon capture and mineralization technology to reuse industrial wastes from the concrete industry

CleanTech

IP Group holding: 34.0%*

Long-range and efficient eVTOL

CleanTech

IP Group holding: 1.1%*

Biopharmaceutical company translating breakthroughs in biology and basic medical research into innovative new medicines

HealthTech

IP Group holding: 23.9%*

Unique solutions for encapsulation based on cutting-edge research

DeepTech

IP Group holding: 6.8%*

Novel oncology therapies that leverage the changes in the DNA Damage Response (DDR) in cancer cells

HealthTech

IP Group holding: 38.4%*

Personalised, trackable 3D sound projection technology

DeepTech

IP Group holding: 30.7%*

Novel heat exchanger technology

CleanTech

IP Group holding: 0.4%*

Clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients

HealthTech

IP Group holding: 13.5%*

Immuno-oncology company developing novel, targeted T cell enhancing therapeutics

HealthTech

IP Group holding: 27.0%*

AI automation of computer code testing

DeepTech

IP Group holding: 19.6%*

Novel disease modifying medications for respiratory disease

HealthTech

IP Group holding: 27.5%*

Solving fusion with the simplest possible machine.

CleanTech

IP Group holding: 17.1%*

End-to-end fraud prevention using AI and machine learning to enhance real time detection and reduce false positives

DeepTech

IP Group holding: 11.3%*

Using large-scale genetic information to develop precision healthcare tools and to bring new understanding to drug discover

HealthTech

IP Group holding: 36.8%*

Mobile assessment and training platform for home-based upper limb rehabilitation

HealthTech

IP Group holding: 13.5%*

Perovskite-based light-emitting devices for next-gen displays

DeepTech

IP Group holding: 0.6%*

Digital clinic for joint and muscle care

HealthTech

IP Group holding: 37.0%*

Developing a new type of breakthrough hydrogen electrolyser and accelerating the global transition to net zero

CleanTech
Top 10 holdings

IP Group holding: 46.4%*

Software for the early identification of osteoporosis from an X-ray image

HealthTech

IP Group holding: 11.6%*

Creating scalable, effective, and highly personalised digital mental health products

HealthTech

IP Group holding: 15.8%*

Next-generation antibody-drug conjugates (ADCs) for cancer therapy

HealthTech

IP Group holding: 26.0%*

Early-stage drug discovery using insulin-regulated aminopeptidase (IRAP) as a novel target in fibrosis

HealthTech

IP Group holding: 28.2%*

Silicon-based resistive random access memory (RRAM) technology

DeepTech

IP Group holding: 56.5%*

From disease modification to disease resolution

HealthTech
Top 10 holdings

IP Group holding: 8.3%*

Novel polymers, e.g. "removable chewing gum"

DeepTech

IP Group holding: 25.3%*

Global leader in vision-based patient monitoring systems

HealthTech

IP Group holding: 26.3%*

Delivering optical computing for next-generation AI

DeepTech

IP Group holding: 50.0%*

Contactless, lubricant-free magnetic gear systems

CleanTech

IP Group holding: 15.2%*

Advanced geological-based prediction and detection technology to source natural hydrogen

CleanTech

IP Group holding: 16.7%*

Microbiome based therapeutics and diagnostics

HealthTech

IP Group holding: 22.3%*

Drug development company targeting the ubiquitin pathway for the treatment of serious diseases

HealthTech
Top 10 holdings

IP Group holding: 17.0%*

Internet of Tanks reducing energy consumption and enabling renewables

CleanTech

IP Group holding: 8.6%*

Focused on the discovery of a new generation of sustainable herbicides.

HealthTech

IP Group holding: 3.9%*

Silicon anodes for next generation lithium-ion batteries

CleanTech
Top 10 holdings

IP Group holding: 10.6%*

Software to enable every vehicle to become autonomous

CleanTech
Top 10 holdings

IP Group holding: 15.2%*

Catalyst to convert CO2 and Hydrogen into synthetic fuels

CleanTech

IP Group holding: 8.4%*

Enabling the analysis of any living thing, by any person, in any environment using real-time DNA/RNA sequencing

HealthTech
Top 10 holdings

IP Group holding: 1.4%*

Achieving quantum computing through super conducting circuits

DeepTech

IP Group holding: 1.5%*

Contractually preferred partner of the University of Oxford to develop spin-out companies based on divisional research

Economic value: £128m

Rights to receive royalties from obesity drug programmes

HealthTech
Top 10 holdings

IP Group holding: 11.9%*

Novel inhaled treatment for life-threatening fungal lung infections

HealthTech

IP Group holding: 17.0%*

The world’s first compact completely embedded self-certified quantum random number generator

DeepTech

IP Group holding: 7.3%*

Creating a scalable, high-density quantum computer on a silicon chip for the cloud

DeepTech

IP Group holding: 61.3%*

Novel therapies for chronic respiratory inflammation

HealthTech

IP Group holding: 18.9%*

Real-time monitoring of people and assets in harsh, dynamic environments

DeepTech

IP Group holding: 12.6%*

Visual tracking and mapping systems or 'Simultaneous Localisation and Mapping' (SLAM)

DeepTech

IP Group holding: 14.8%*

Clinical stage biotechnology company creating novel therapies that inhibit RNA modifying enzymes for use in oncology

HealthTech

IP Group holding: 18.6%*

Global leader in stray light suppression coating technology

DeepTech

IP Group holding: 1.6%*

Smart home climate management and smart energy tariffs

CleanTech

IP Group holding: -%*

Fast and secure payment solutions that can help businesses to better manage and grow their operations

DeepTech

IP Group holding: 20.4%*

Removing boundaries between physical and digital worlds - for anyone, anywhere

DeepTech

IP Group holding: 9.0%*

Reusable packing-as-a-service for food take-away and delivery

CleanTech

Backing the daring, rewarding the brave.